Abstract
Purpose
This study aims to determine the relationship between bone destruction and bone turnover markers in patients with chronic otitis media (COM).
Methods
Subjects with COM were divided into two groups: those with and without bone destruction. Thirty-seven patients were included in the group with bone destruction; 30 patients were included in the group without bone destruction. The enzyme values were evaluated.
Results
There was no difference between the two groups in terms of enzyme levels of serum and urine. However, the osteocalcin, which is a bone formation marker, and the C-terminal telopeptide of type I collagen marker, which is bone destruction marker, were found to be lower in the group with bone destruction than the group without bone destruction.
Conclusion
Data obtained in the present study suggest that the pressure necrosis theory and acid lysis theory provide the most valid explanations of bone destruction. However, the data provide limited preliminary information to clarify this mechanism.
Similar content being viewed by others
References
Master A, Wilkinson E, Wagner R (2018) Management of chronic suppurative otitis media and otosclerosis in developing countries. Otolaryngol Clin North Am 51(3):593–605. https://doi.org/10.1016/j.otc.2018.01.017
Gerami H, Naghavi E, Wahabi-Moghadam M, Forghanparast K, Akbar MH (2009) Comparison of preoperative computerized tomography scan imaging of temporal bone with the intra-operative findings in patients undergoing mastoidectomy. Saudi Med J 30(1):104–108
Peek F, Huisman M, Berckmans R, Sturk A, van Loon J, Grote J (2003) Lipopolysaccharide concentration and bone resorption in cholesteatoma. Otol Neurotol 24(5):709–713
Xie S, Wang X, Ren J, Liu W (2017) The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma. Eur Arch Otorhinolaryngol 274(5):2071–2078. https://doi.org/10.1007/s00405-016-4422-6
Hlaing TT, Compston JE (2014) Biochemical markers of bone turnover - uses and limitations. Ann Clin Biochem 51(Pt 2):189–202. https://doi.org/10.1177/0004563213515190
Konukoglu D (2019) Bone markers. Int J Med Biochem 2(2):65–78
Nguyen KH, Suzuki H, Ohbuchi T, Wakasugi T, Koizumi H, Hashida K, Baba R, Morimoto H, Doi Y (2014) Possible participation of acidic pH in bone resorption in middle ear cholesteatoma. Laryngoscope 124(1):245–250
Si Y, Chen YB, Chen SJ, Zheng YQ, Liu X, Liu Y, Jiang HL, Xu G, Li ZH, Huang QH (2015) TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction. Sci Rep 5:16683
Iwamoto Y, Nishikawa K, Imai R, Furuya M, Uenaka M, Ohta Y, Morihana T, Itoi-Ochi S, Penninger JM, Katayama I, Inohara H, Ishii M (2016) Intercellular communication between keratinocytes and fibroblasts induces local osteoclast differentiation: a mechanism underlying cholesteatoma-induced bone destruction. Mol Cell Biol 36(11):1610–1620. https://doi.org/10.1128/mcb.01028-15
Jeong JH, Park CW, Tae K, Lee SH, Shin DH, Kim KR, Park YW (2006) Expression of RANKL and OPG in middle ear cholesteatoma tissue. Laryngoscope 116(7):1180–1184. https://doi.org/10.1097/01.mlg.0000224345.59291.da
Chen AP, Wang B, Zhong F, Song GZ, Song HF, Yu K, Wang HB, Jiang ZH (2015) Expression levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin are associated with middle ear cholesteatoma risk. Acta Otolaryngol 135(7):655–666. https://doi.org/10.3109/00016489.2015.1011789
Abramson M, Moriyama H, Huang CC (1984) Pathogenic factors in bone resorption in cholesteatoma. Acta Otolaryngol 97(5–6):437–442. https://doi.org/10.3109/00016488409132918
Macri JR, Chole RA (1985) Bone erosion in experimental cholesteatoma–the effects of implanted barriers. Otolaryngol Head Neck Surg 93(1):3–17. https://doi.org/10.1177/019459988509300102
Yetişer S, Hıdır Y, Deveci MS (2005) Morphologic changes of middle ear mucosa in chronic otitis media with or without cholesteatoma. The Mediterr J Otol 4:102–108
Funding
This study was support of the Scientific Research Projects Coordinatorship of the University of Health Sciences (Project No: 2018/021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no confict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (University of Health Sciences Samsun Education and Research Hospital Clinical Research Ethics Committee dated 08.02.2018 and numbered 2018/23) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yemiş, T., Özgür, A., Başbulut, E. et al. Bone turnover in chronic otitis media with bone destruction. Eur Arch Otorhinolaryngol 277, 2229–2233 (2020). https://doi.org/10.1007/s00405-020-05970-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-020-05970-4